Avadel Pharmaceuticals Statistics, Revenue Totals, Facts & News (2022)
Last Updated on: July 18th, 2021
Here are a few of the most interesting Avadel Pharmaceuticals statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Avadel Pharmaceuticals Facts
- Website: Official Website
- Year Founded: 1990
- Headquarters: Dublin, Ireland
- Current Chief Executive: Michael Anderson
What is Avadel Pharmaceuticals?
Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. Avadel’s current portfolio of products and product candidates focuses on the central nervous system (CNS) / sleep and hospital markets. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. (source)
Avadel Pharmaceuticals Employee Count
Number of Avadel Pharmaceuticals employees:
Last updated 1/1/20
Avadel Pharmaceuticals Revenue Totals
Avadel Pharmaceuticals annual revenue:
- 2019: $59.215 million
- 2018: $103.269 million
- 2017: $173.245 million
- 2016: $150.246 million
- 2015: $173.009 million
Avadel Pharmaceuticals annual net income:
- 2019: $33.226 million net loss
- 2018: $95.304 million net loss
- 2017: $68.271 million
- 2016: $41.276 million net loss
- 2015: $41.798 million
Please note that some of these numbers are easier to find than others. A few of these Avadel Pharmaceuticals stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.